Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
China Shineway Pharmaceutical Group Limited ( (HK:2877) ) has shared an announcement.
China Shineway Pharmaceutical Group Limited has announced a board meeting scheduled for 27 August 2025. The meeting will address the approval of the company’s interim results for the first half of 2025 and the consideration of a dividend declaration, reflecting the company’s ongoing financial management and potential shareholder returns.
More about China Shineway Pharmaceutical Group Limited
China Shineway Pharmaceutical Group Limited is a company incorporated in the Cayman Islands, focusing on the pharmaceutical industry. It is involved in the production and distribution of pharmaceutical products, serving a diverse market with a range of healthcare solutions.
Average Trading Volume: 1,089,005
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$6.25B
For an in-depth examination of 2877 stock, go to TipRanks’ Overview page.